Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
Authors:
Open Access
- 6 December 2019
- journal article
- review article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2019, 1-12
Abstract
Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in patients with atrial fibrillation (AF), and T2D patients with AF-associated stroke seem to have worse clinical outcome and higher risk of unfavorable clinical course compared to individuals without this metabolic disorder. Long-term anticoagulation is indicated in majority of T2D patients with AF to prevent adverse AF-associated embolic events. Direct oral anticoagulants (DOACs), direct oral thrombin inhibitor dabigatran, and direct oral factor Xa inhibitors, rivaroxaban, apixaban, and edoxaban, have emerged as a preferred choice for long-term prevention of stroke in AF patients offering potent and predictable anticoagulation and a favorable pharmacology with low risk of interactions. This article reviews the current data regarding the use of DOACs in individuals with T2D and AF.Keywords
Funding Information
- Agentúra na Podporu Výskumu a Vývoja (16-0020)
This publication has 84 references indexed in Scilit:
- Role of diabetes and insulin use in the risk of stroke and acute myocardial infarction in patients with atrial fibrillation: A Medicare analysisAmerican Heart Journal, 2019
- Stroke Outcome and Determinants among Patients with and without Diabetes in a Tertiary Hospital in GhanaStroke Research and Treatment, 2018
- Diabetes and ischaemic stroke outcomeDiabetic Medicine, 2018
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEuropean Heart Journal, 2016
- Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practiceArchives of Cardiovascular Diseases, 2015
- Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities studyHeart, 2011
- Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial FibrillationThe American Journal of Cardiology, 2011
- Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial FibrillationDiabetes Care, 2009
- Impact of comorbidity on ischemic stroke outcomeActa Neurologica Scandinavica, 2005
- Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish communityDiabetes, Obesity and Metabolism, 2004